GR3005444T3 - - Google Patents
Info
- Publication number
- GR3005444T3 GR3005444T3 GR910402023T GR910402023T GR3005444T3 GR 3005444 T3 GR3005444 T3 GR 3005444T3 GR 910402023 T GR910402023 T GR 910402023T GR 910402023 T GR910402023 T GR 910402023T GR 3005444 T3 GR3005444 T3 GR 3005444T3
- Authority
- GR
- Greece
- Prior art keywords
- antagonize
- chem
- compound
- formula
- effects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15386488A | 1988-02-09 | 1988-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3005444T3 true GR3005444T3 (el) | 1993-05-24 |
Family
ID=22549061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR910402023T GR3005444T3 (el) | 1988-02-09 | 1992-08-20 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0328282B1 (el) |
JP (1) | JPH01265076A (el) |
AT (1) | ATE79540T1 (el) |
DE (1) | DE68902490T2 (el) |
ES (1) | ES2051996T3 (el) |
GR (1) | GR3005444T3 (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4795468A (en) * | 1987-12-23 | 1989-01-03 | Zimmer, Inc. | Mechanism and method for locking a bearing insert to the base of a prosthetic implant |
US7465795B2 (en) | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof |
BRPI0620126A2 (pt) | 2005-12-20 | 2011-11-01 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, método para modular a atividade de um receptor de gabaa, e, método sintético para fabricar um composto |
TW200911760A (en) * | 2007-06-19 | 2009-03-16 | Astrazeneca Ab | Compounds and uses thereof |
WO2010123441A1 (en) * | 2009-04-21 | 2010-10-28 | Astrazeneca Ab | Crystalline form of 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3- carboxamide hydrogen sulphate, for treatment of anxiety disorders |
WO2010123443A1 (en) * | 2009-04-21 | 2010-10-28 | Astrazeneca Ab | Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate. |
WO2010123440A1 (en) * | 2009-04-21 | 2010-10-28 | Astrazeneca Ab | Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate and rate-controlling polymer |
WO2011021979A1 (en) * | 2009-08-18 | 2011-02-24 | Astrazeneca Ab | Cinnoline compounds, their preparation, and their use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8513639D0 (en) * | 1985-05-30 | 1985-07-03 | Ici America Inc | Cinnoline compounds |
US4965264A (en) * | 1987-03-25 | 1990-10-23 | Yoshitomi Pharmaceutical Industries, Ltd. | Thienocinnoline compounds and their pharmaceutical use |
-
1989
- 1989-01-30 ES ES89300865T patent/ES2051996T3/es not_active Expired - Lifetime
- 1989-01-30 AT AT89300865T patent/ATE79540T1/de not_active IP Right Cessation
- 1989-01-30 EP EP89300865A patent/EP0328282B1/en not_active Expired - Lifetime
- 1989-01-30 DE DE8989300865T patent/DE68902490T2/de not_active Expired - Lifetime
- 1989-02-09 JP JP1030916A patent/JPH01265076A/ja active Pending
-
1992
- 1992-08-20 GR GR910402023T patent/GR3005444T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0328282A2 (en) | 1989-08-16 |
DE68902490D1 (de) | 1992-09-24 |
ATE79540T1 (de) | 1992-09-15 |
ES2051996T3 (es) | 1994-07-01 |
EP0328282B1 (en) | 1992-08-19 |
DE68902490T2 (de) | 1992-12-24 |
EP0328282A3 (en) | 1990-04-25 |
JPH01265076A (ja) | 1989-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4415285A (en) | Benzodiazepine derivatives | |
GR3024255T3 (en) | Benzo-fused lactams | |
EP0455510A3 (en) | Use of 5-ht1a receptor agonist compounds for inhibiting gastric acid secretion | |
GR3004139T3 (el) | ||
GR3030718T3 (en) | Novel prostaglandin analogue. | |
GR3005444T3 (el) | ||
JPS6416781A (en) | Cycloalkylamides of (8 beta)-1-alkyl-6- (substituted)ergoline | |
DE3870954D1 (de) | Zahnaerztliche haftmittelzusammensetzung. | |
CA2012081A1 (en) | 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi 2 derivatives | |
AU2051288A (en) | Process for the synthesis of dimer alkaloid compounds | |
AU2752688A (en) | N-formulated hindered amine light stabilisers for coatings | |
KR880700667A (ko) | 정신병 치료제로서의 2,3-디히드로-1h-페날렌-2-아미노화합물 | |
RO91594B (ro) | Compozitie erbicida solida | |
ES2164258T3 (es) | Procedimiento de preparacion de derivados de carbamoilmetilurea. | |
PH24927A (en) | Derivatives of substituted 1,2,3-thiadiazole-4-thiolate compounds |